Johnson & Johnson says booster shot of its COVID-19 vaccine strengthens immunity
CBSN
Johnson & Johnson said Wednesday that a second shot of its COVID-19 vaccine eight months after the initial dose was found in a study to increase people's immunity to the disease.
The drugmaker has been testing the efficacy of boosters in people who were previously injected with its single-dose vaccine. The latest findings show that individuals who received an additional shot saw a ninefold increase in antibody levels, according to J&J. The company said researchers observed a "rapid and robust" increase in antibodies in people ages 18 to 55 and in those 65 years and older who received a lower booster dose. While the company's single-shot vaccine stimulates a strong immune response, "With these new data, we also see that a booster dose of the Johnson & Johnson COVID-19 vaccine further increases antibody responses among study participants who had previously received our vaccine," said Dr. Mathai Mammen, global head of research and development at Johnson & Johnson's Janssen Pharmaceuticals, in a statement.
A panel of appeals court judges handed the Trump administration a major legal victory on Wednesday in its quest to detain large swaths of immigrants living in the country illegally, saying that people who entered the United States without inspection and admission can be detained without bond. Jonah Kaplan and Camilo Montoya-Galvez contributed to this report.

A jury on Wednesday found that Meta and YouTube are liable for creating products that led to harmful and addictive behavior by young users, a landmark decision that could set a legal precedent for similar allegations brought against social media companies. Edited by Alain Sherter and Aimee Picchi In:











